Oncolytics Biotech Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Jul 16, 2025 · CIK: 1129928
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Oncolytics Biotech filed a routine 6-K, no major news.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on July 16, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a pharmaceutical preparations company and is subject to the 1934 Securities Exchange Act. This filing does not appear to contain specific financial or operational updates beyond its status as a periodic report.
Why It Matters
This filing indicates Oncolytics Biotech Inc. is meeting its reporting obligations as a foreign private issuer, which is standard for publicly traded companies operating internationally.
Risk Assessment
Risk Level: low — This is a standard periodic filing by a foreign private issuer and does not contain new material information that would inherently increase risk.
Key Players & Entities
- Oncolytics Biotech Inc. (company) — Filer of the 6-K report
- July 16, 2025 (date) — Filing date of the 6-K
- Calgary, Alberta, Canada (location) — Company's principal executive offices
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes public in its home country, files with a stock exchange, or distributes to its security holders.
When was this Form 6-K filed?
This Form 6-K was filed on July 16, 2025.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Does this filing indicate a new annual report submission?
The filing indicates whether the registrant files annual reports under Form 20-F or Form 40-F, but this specific 6-K filing itself is not an annual report.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 16, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).